HEAD AND NECK CANCERS
Clinical trials for HEAD AND NECK CANCERS explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCERS trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced cancers: IDE161 trial begins
Disease control Recruiting nowThis study tests a new drug called IDE161, alone or with another drug (pembrolizumab), in people with advanced solid tumors (like breast, ovarian, prostate, or lung cancer). The goal is to find a safe dose and see if it can shrink tumors. About 216 adults with tumors that have sp…
Matched conditions: HEAD AND NECK CANCERS
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated May 26, 2026 04:11 UTC
-
New virus therapy targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-stage study tests a new treatment called IDOV-Immune, a virus designed to infect and kill cancer cells and boost the immune system. It is for adults with advanced solid tumors (like colorectal, pancreatic, or lung cancer) that have not responded to standard treatments.…
Matched conditions: HEAD AND NECK CANCERS
Phase: PHASE1 • Sponsor: ViroMissile, Inc. • Aim: Disease control
Last updated May 26, 2026 03:58 UTC
-
New hope for tough cancers: experimental drug VMD-928 enters human trials
Disease control Recruiting nowThis study tests an experimental drug called VMD-928, taken as a pill, either alone or with another drug (pembrolizumab), in people with advanced solid tumors or lymphoma that have stopped responding to standard treatments. The goal is to find a safe dose and see if it can shrink…
Matched conditions: HEAD AND NECK CANCERS
Phase: PHASE1, PHASE2 • Sponsor: VM Oncology, LLC • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
New drug EPI-326 enters first human tests for tough cancers
Disease control Recruiting nowThis early-phase study tests a new drug called EPI-326 in about 110 people with advanced lung cancer (with a specific EGFR gene change) or head/neck cancer. The main goal is to check safety and find the best dose. Participants receive the drug and are monitored for side effects a…
Matched conditions: HEAD AND NECK CANCERS
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Sharper scans could make cancer radiation more precise
Knowledge-focused Recruiting nowThis study is testing a new type of CT scan called HyperSight, which is built into a radiation therapy machine. The goal is to see if it produces clearer images than current scans, which could help doctors target tumors more accurately. About 50 adults with various cancers (head …
Matched conditions: HEAD AND NECK CANCERS
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Knowledge-focused
Last updated May 26, 2026 03:52 UTC
-
Mapping the road to recovery: new study tracks care paths for head and neck cancer reconstruction
Knowledge-focused Recruiting nowThis study looks at the usual care path for 200 adults who need facial bone reconstruction after surgery for head and neck cancer. Researchers will analyze health records to see what treatments, hospital visits, and medications patients typically receive. The goal is to better un…
Matched conditions: HEAD AND NECK CANCERS
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC